Lumida
/RNST
⌘K
Renasant Corp

Renasant Corp

RNST
$40.77USD+0.59%+0.24 today

MARKET CAP

3.7B

P/E (TTM)

11.4x

FWD P/E

10.4x

DAY RANGE

$40 – $41

52W RANGE

$33
$45

AI Summary

Stalk
Buy NowMedium

RNST remains in a Stage 2 uptrend characterized by higher highs and lows, but the recent Bullish Exhaustion signal highlights near-term buyer fatigue. Price is currently pulling back into the rising 9/20 EMA support zone, offering a favorable entry point. Medium-term momentum remains intact, and buying now near short-term EMA support aligns with continuation participation. A sustained break below the 50-day SMA would invalidate this bullish bias.

  • Adjusted EPS rose 36% YoY to $0.94 in Q2 2026.
  • Efficiency ratio improved to 57.9% from 67.6% YoY.
  • Negative profitability and revision momentum indicate margin pressure.
Full analysis →

Buying

4

institutions

Selling

4

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

SELL13.32 M566.68 M+-305.11 K+15.1%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY1.14 M48.48 M+750.35 K+244.7%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL148.70 K6.53 M+-121.52 K-31.7%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY90.86 K3.28 M+45.43 K+105.2%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY61.81 K2.63 M+15.96 K+58.7%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW5.21 K221.85 K+5.21 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL314.0013.36 K+-243.00-33.6%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL0.000.00+-55.94 K-100.0%0.00%